CPC A61K 31/353 (2013.01) [A61K 31/05 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/235 (2013.01); A61K 31/465 (2013.01); A61K 31/522 (2013.01); A61K 45/06 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01)] | 20 Claims |
1. A method of inhibiting, ameliorating, reducing the likelihood, delaying the onset of, or treating a microbially induced amyloid disorder, the method comprising administering to a subject in need thereof a composition comprising a compound selected from the group consisting of: epigallocatechin gallate, quercetin, morin, rosmarinic acid, gallic acid, lauryl gallate, methoxyhydroquinone, curcumin, resveratrol, apigenin, nordihydroguaiaretic acid, phloretin and genistein; or pharmaceutically acceptable salts thereof.
|